Pioneer Trust Bank N A Lifted 3M Co Com (MMM) Holding by $547,820; Pfizer (PFE) Shareholder Advisor Partners Boosted Its Position by $341,640

Pfizer Inc. (NYSE:PFE) Logo

Advisor Partners Llc increased its stake in Pfizer Inc. (PFE) by 6.74% based on its latest 2018Q2 regulatory filing with the SEC. Advisor Partners Llc bought 9,490 shares as the company’s stock rose 17.09% with the market. The institutional investor held 150,279 shares of the health care company at the end of 2018Q2, valued at $5.45 million, up from 140,789 at the end of the previous reported quarter. Advisor Partners Llc who had been investing in Pfizer Inc. for a number of months, seems to be bullish on the $253.88 billion market cap company. The stock decreased 2.36% or $1.06 during the last trading session, reaching $43.92. About 26.53 million shares traded or 17.83% up from the average. Pfizer Inc. (NYSE:PFE) has risen 19.90% since December 8, 2017 and is uptrending. It has outperformed by 4.28% the S&P500. Some Historical PFE News: 22/03/2018 – GSK advances in Pfizer consumer health auction as Reckitt quits; 29/05/2018 – Phase lll lMpower130 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Helped People With Metastatic Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to; 19/03/2018 – ASTELLAS: FDA GRANTS PRIORITY REVIEW FOR SNDA FOR XTANDI; 01/05/2018 – Pfizer Sales Disappoint as Investors Wait for Strategic M&A; 05/04/2018 – Pfizer Closes Below 50-Day Moving Average: Technicals; 15/05/2018 – PFIZER INC – RETACRIT IS EXPECTED TO BE AVAILABLE IN U.S. AT A SIGNIFICANT DISCOUNT TO CURRENT WHOLESALER ACQUISITION COST OF EPOGEN AND PROCRIT; 18/04/2018 – PROVECTUS BIOPHARMACEUTICALS EXPANDS GLOBAL PATENT PORTFOLIO FOR CANCER COMBINATION THERAPY; 15/05/2018 – Pfizer Biosimilar RETACRIT (Epoetin Alfa-Epbx) Approved by U.S. FDA; 10/04/2018 – PFIZER – INDEPENDENT COMMITTEE FOR PHASE 3 ATLAS TRIAL OF INLYTA RECOMMENDED STOPPING TRIAL AT A PLANNED INTERIM ANALYSIS DUE TO FUTILITY; 03/04/2018 – Pfizer in talks with P&G on sale of its consumer business, though they are far apart on price

Pioneer Trust Bank N A increased its stake in 3M Co Com (MMM) by 136.27% based on its latest 2018Q2 regulatory filing with the SEC. Pioneer Trust Bank N A bought 2,795 shares as the company’s stock rose 0.89% with the market. The institutional investor held 4,846 shares of the medical and dental instruments company at the end of 2018Q2, valued at $953,000, up from 2,051 at the end of the previous reported quarter. Pioneer Trust Bank N A who had been investing in 3M Co Com for a number of months, seems to be bullish on the $115.43B market cap company. The stock decreased 2.19% or $4.44 during the last trading session, reaching $198.24. About 2.25M shares traded. 3M Company (NYSE:MMM) has declined 1.40% since December 8, 2017 and is downtrending. It has underperformed by 17.02% the S&P500. Some Historical MMM News: 24/04/2018 – 3M sinks 8%, eyes biggest drop since 2006; 05/03/2018 – CNBC Now: BREAKING: 3M appoints Michael F. Roman as CEO,effective July 1. Current CEO Inge Thulin becomes executive; 24/04/2018 – 3M CO – FOREIGN CURRENCY TRANSLATION IN QTR INCREASED SALES BY 4.2 PERCENT YEAR-ON-YEAR; 21/05/2018 – 3M Forms Sustainability and Product Stewardship Organization; Names Dr. Gayle Schueller Next Chief Sustainability Officer; 04/04/2018 – 3M Announces New Leadership Appointment; 24/04/2018 – PAVILLON: 3M UNPAID LEAVE FOR ZHENG FENGWEN, EXEC DIRECTOR, CEO; 24/04/2018 – 3M CO MMM.N SEES FY 2018 GAAP SHR $8.68 TO $9.03; 08/05/2018 – 3M CO SAYS EXPECTS FY 2018 GROSS SHARE REPURCHASES WILL BE IN THE RANGE OF $3.0 BLN TO $5.0 BLN – SEC FILING; 13/03/2018 – Communicating In Tough Conditions Just Got Easier With New Post-it Extreme Notes; 30/05/2018 – 3M INDIA 4Q NET INCOME 930.5M RUPEES

Among 17 analysts covering 3M (NYSE:MMM), 7 have Buy rating, 3 Sell and 7 Hold. Therefore 41% are positive. 3M had 106 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Underperform” on Friday, October 23. The firm earned “Buy” rating on Monday, October 9 by Citigroup. The firm has “Hold” rating by RBC Capital Markets given on Tuesday, July 25. The company was maintained on Tuesday, December 12 by RBC Capital Markets. The firm earned “Hold” rating on Wednesday, December 13 by Stifel Nicolaus. The rating was maintained by UBS with “Neutral” on Wednesday, October 24. The stock of 3M Company (NYSE:MMM) has “Underweight” rating given on Monday, October 2 by Morgan Stanley. Deutsche Bank maintained it with “Hold” rating and $208 target in Thursday, July 12 report. RBC Capital Markets maintained the shares of MMM in report on Thursday, January 25 with “Hold” rating. The firm earned “Buy” rating on Monday, May 29 by Jefferies.

Since September 10, 2018, it had 1 insider buy, and 1 insider sale for $90,252 activity. PAGE GREGORY R had bought 1,000 shares worth $184,500 on Friday, October 26.

Pioneer Trust Bank N A, which manages about $208.62M US Long portfolio, decreased its stake in Amgen Inc Com (NASDAQ:AMGN) by 2,080 shares to 16,240 shares, valued at $3.00 million in 2018Q2, according to the filing.

Investors sentiment increased to 0.97 in Q2 2018. Its up 0.20, from 0.77 in 2018Q1. It increased, as 73 investors sold MMM shares while 549 reduced holdings. 111 funds opened positions while 490 raised stakes. 374.25 million shares or 0.96% less from 377.88 million shares in 2018Q1 were reported. Virtu Financial Ltd reported 2,978 shares. Osborne Prns Mgmt Ltd Co invested in 0.06% or 2,266 shares. Kanawha Mngmt Limited Liability Company reported 61,406 shares. Cypress Asset Mgmt Tx, Texas-based fund reported 12,424 shares. Ingalls And Snyder Lc reported 0.09% stake. Capwealth Ltd Company stated it has 38,719 shares. Catawba Capital Va reported 0.92% stake. Moreover, Wallington Asset Mgmt Llc has 3.34% invested in 3M Company (NYSE:MMM). Waters Parkerson And Limited Com invested 0.42% of its portfolio in 3M Company (NYSE:MMM). Crestwood Group Inc Limited Liability Company, Massachusetts-based fund reported 85,644 shares. Atlas Browninc reported 8,118 shares. 29,500 were reported by Opus Inv Mgmt. Cs Mckee Limited Partnership holds 0.95% of its portfolio in 3M Company (NYSE:MMM) for 56,750 shares. 9,201 were reported by Forward Mngmt Ltd Llc. Gould Asset Ltd Liability Ca stated it has 21,373 shares.

More notable recent 3M Company (NYSE:MMM) news were published by: Investorplace.com which released: “Should You Buy Boeing Stock at Current Levels? – Investorplace.com” on December 07, 2018, also Seekingalpha.com with their article: “3M: Optimistic, But A Few Caveats – Seeking Alpha” published on November 11, 2018, Bizjournals.com published: “3M’s new products must meet sustainability goals, company says – Minneapolis / St. Paul Business Journal” on December 05, 2018. More interesting news about 3M Company (NYSE:MMM) were released by: Streetinsider.com and their article: “3M Co. (MMM) Declares $1.36 Quarterly Dividend and Approves $10B Buyback – StreetInsider.com” published on November 13, 2018 as well as Fool.com‘s news article titled: “Will 3M’s New 5-Year Financial Plan Help the Stock Recover? – The Motley Fool” with publication date: December 01, 2018.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Fool.com which released: “Better Buy: Pfizer vs. Bristol-Myers Squibb – The Motley Fool” on November 25, 2018, also Seekingalpha.com with their article: “Pfizer’s Rituxan biosimilar successful in late-stage study; shares up 1% premarket – Seeking Alpha” published on December 03, 2018, Investorplace.com published: “Monday’s Vital Data: Pfizer, Goldman Sachs and Caterpillar – Investorplace.com” on December 03, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer Inc. (PFE) Management Presents on Evercore ISI HealthCONx Conference Call Transcript – Seeking Alpha” published on November 28, 2018 as well as Fool.com‘s news article titled: “3 Big Pharma Stocks Hitting 52-Week Highs — Are They Buys? – Motley Fool” with publication date: December 04, 2018.

Investors sentiment decreased to 0.78 in Q2 2018. Its down 0.11, from 0.89 in 2018Q1. It worsened, as 52 investors sold PFE shares while 754 reduced holdings. 112 funds opened positions while 518 raised stakes. 3.98 billion shares or 0.73% less from 4.01 billion shares in 2018Q1 were reported. Mackenzie Corporation has 4.69M shares for 0.43% of their portfolio. Nippon Life Insurance Com holds 0.85% or 1.03 million shares. Kbc Group Nv reported 1.09% in Pfizer Inc. (NYSE:PFE). King Luther Capital Mngmt owns 3.07M shares. Edgewood Ltd Liability Company holds 0.01% of its portfolio in Pfizer Inc. (NYSE:PFE) for 96,990 shares. Jones Financial Lllp holds 370,668 shares. Bahl And Gaynor Inc has 1.16% invested in Pfizer Inc. (NYSE:PFE) for 3.05M shares. Eqis Cap Mgmt reported 91,232 shares. Tocqueville Asset Management Lp has 0.68% invested in Pfizer Inc. (NYSE:PFE) for 1.49M shares. Fort Point Partners Limited holds 0.12% in Pfizer Inc. (NYSE:PFE) or 9,775 shares. Cambridge invested 0.22% of its portfolio in Pfizer Inc. (NYSE:PFE). Overbrook Mngmt Corporation invested in 37,741 shares or 0.26% of the stock. Bristol John W & Incorporated Ny holds 5,250 shares. Atwood & Palmer holds 0.09% in Pfizer Inc. (NYSE:PFE) or 18,513 shares. Meridian Mgmt Com holds 31,182 shares or 0.52% of its portfolio.

Among 23 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 13 Hold. Therefore 39% are positive. Pfizer had 88 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Monday, April 18 by Goldman Sachs. The rating was initiated by Guggenheim on Friday, December 2 with “Neutral”. The rating was upgraded by Morgan Stanley to “Overweight” on Wednesday, September 20. On Wednesday, November 25 the stock rating was upgraded by Suntrust Robinson to “Neutral”. The rating was maintained by Credit Suisse with “Outperform” on Monday, May 9. S&P Research maintained Pfizer Inc. (NYSE:PFE) on Wednesday, October 28 with “Hold” rating. The rating was maintained by Credit Suisse on Wednesday, January 31 with “Neutral”. Morgan Stanley maintained it with “Overweight” rating and $43 target in Wednesday, January 31 report. As per Wednesday, April 6, the company rating was initiated by Societe Generale. The stock of Pfizer Inc. (NYSE:PFE) earned “Hold” rating by BMO Capital Markets on Monday, June 12.

Advisor Partners Llc, which manages about $240.00M and $591.37M US Long portfolio, decreased its stake in International Business Machine (NYSE:IBM) by 2,917 shares to 14,007 shares, valued at $1.96 million in 2018Q2, according to the filing.

Since June 6, 2018, it had 0 buys, and 2 insider sales for $1.92 million activity. OLSON LAURIE J had sold 19,000 shares worth $692,582.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.